Stay updated on CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page.

Latest updates to the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page
- Check4 days agoChange DetectedThe page shows a new Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's build or metadata rather than its content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now includes an additional listed PubMed publication citation about immunogenicity outcomes in subcutaneous infliximab recipients. It also updates the site’s revision/version label from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a new PubMed citation to the Publications section: Schreiber S, Sands BE, Danese S, Loftus EV Jr, Jeong AL, Kim DH, Lee YN, Colombel JF. Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial. Adv Ther. 2026 Mar 30. Online ahead of print.SummaryDifference0.0%

- Check61 days agoChange DetectedPublication added: Dubinsky MC et al. Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of LIBERTY-CD & LIBERTY-UC trials; Revision: v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check76 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study content, eligibility criteria, or data presented on the page appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in Active Crohn's: LIBERTY-CD Clinical Trial page.